dihexa pnb-0408 mechanism of action (PNB-0408) — Dosing, Side Effects, FDA Status & Research | PeptIQ Dihexa (also known as PNB-0408)
Dihexa (also known as PNB 0408) is an experimental small molecule derived from angiotensin IV. It was engineered to cross the bloodbrain barrier and has shown synaptogenic effects in preclinical models. The often quoted Computationally Guided Design, Synthesis, and Evaluation of Novel Non Hydroxamic Histone Deacetylase Inhibitors, Based on N Trifluoroacetamide as a Zinc Binding Group, Against Breast Cancer dihexa pnb 0408 mechanism of action BDNF peptide: the complete guide to brain derived neurotrophic factor DIHEXA POWDER (1 GRAM) Cognitive peptides in research: Semax, Selank, Dihexa and the new generation of peptide nootropics Lab Peptides France
Pay in 4 interest-free payments of $6.60 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4


